Bone Neoplasms
18
2
2
12
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.6%
1 terminated out of 18 trials
92.3%
+5.8% vs benchmark
22%
4 trials in Phase 3/4
17%
2 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (18)
An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry
Radiotherapy Treatments for Neoplasms of the Limbs
Investigation Into the Safety and Efficacy of ICG-Labeled Fluorescence Imaging Technology in Guiding the Resection of Bone and Soft Tissue Tumors
Safety and Efficacy of an Investigational Drug Versus Placebo in the Treatment of Cancer Pain (0663-083)
Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY)
A Study To Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic Bone Pain Related To Metastatic Cancer
Ewing Sarcoma Family of Tumors (ESFT): A 15-year Experience From a Tertiary Care Cancer Center in Upper Egypt
Malignant Pediatric Soft Tissue & Bone Tumors of the Extremities: A Retrospective Study
Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid
The Palliative Radiotherapy And Inflammation Study - PRAIS
Localized Osteosarcoma in Upper Egypt: A Clinical Prediction Model
FREE Study - Fracture Reduction Evaluation
Pilot Study of Stereotactic Ablation for Oligometastatic Breast Neoplasia in Combination With the Anti-PD-1 Antibody MK-3475
Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases
Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease
Using Mesenchymal Stem Cells to Fill Bone Void Defects in Patients With Benign Bone Lesions
Bonefos and the Consumption of Analgesics
Helical Tomotherapy as a Radiotherapy Technique for Treating Bone Metastases